微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -7.51% | -300.27% | -223.71% | 49/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -2.32% | -255.7% | 66.08% | 41/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -6.84% | -131.08% | -230.43% | 49/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -2.07% | 97.87% | -155.2% | 39/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 3.75% | -88.47% | 151.68% | 31/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 1.49% | 107.08% | 150.34% | 32/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | -2.96% | 74.08% | 96.96% | 47/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -97.27% | -359.47% | -399.2% | 49/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 32.51% | 136.44% | 254.52% | 7/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | -21.04% | -682.16% | -84.24% | 48/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | -11.42% | -197.44% | 46.06% | 43/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | -21.17% | -701.89% | -253.96% | 47/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 13.75% | 309.23% | 611.15% | 12/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | -2.69% | 35.65% | -122.95% | 43/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 11.72% | 666.01% | 543.94% | 2/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | -2.64% | 4.35% | -178.57% | 43/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 3.36% | -75.47% | 180.38% | 22/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | -4.18% | -622.5% | -373.2% | 34/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 1.53% | 342.86% | 155.43% | 12/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | -2.76% | 74.73% | -120.15% | 41/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 13.7% | 1064.79% | 1612.5% | 9/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 0.8% | 123.6% | 226.98% | 24/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | -0.63% | 58.55% | 94.23% | 26/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | -10.92% | -86.35% | -669.01% | 42/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | -1.42% | 77.85% | 58.11% | 26/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | -3.39% | 36.28% | -123.03% | 31/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | -1.52% | 15.56% | 74.06% | 25/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | -5.86% | -0.17% | 8.58% | 38/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | -6.41% | -26.68% | -20.49% | 26/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | -5.32% | -40.37% | -195.56% | 29/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | -1.8% | -37.4% | 69.23% | 21/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | -5.85% | -136.84% | -15.61% | 30/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | -5.06% | -1003.57% | -33.51% | 19/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | -3.79% | 16.7% | -189.31% | 23/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | -1.31% | -165.5% | 46.96% | 18/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | -2.47% | 79.9% | -541.07% | 27/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 0.56% | 115.95% | 112.31% | 16/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | -4.55% | -152.78% | -327.5% | 19/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 2% | 221.95% | 116.27% | 9/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |